Healthcare - Biotechnology - NASDAQ - US
$ 1.59
-1.85 %
$ 43.6 M
Market Cap
-1.92
P/E
BALANCE SHEET
19.9 M
ASSETS
3.72 M
LIABILITIES
16.4 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Immix Biopharma, Inc.
| Current Assets | 19.8 M |
| Cash & Short-Term Investments | 17.5 M |
| Receivables | 1.17 M |
| Other Current Assets | 1.11 M |
| Non-Current Assets | 137 K |
| Long-Term Investments | 0 |
| PP&E | 50.2 K |
| Other Non-Current Assets | 87.2 K |
| Current Liabilities | 3.72 M |
| Accounts Payable | 1.43 M |
| Short-Term Debt | 0 |
| Other Current Liabilities | 2.29 M |
| Non-Current Liabilities | 0 |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 17.5 | 13.4 | 17.6 | 0.4 | 0.7 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.2 | 0.3 | 25.7 K | 0.1 | 0.2 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.1 | 1.2 | 0.5 | 13.7 K | 23.5 K |
| Total Current Assets | 19.8 | 14.9 | 18.2 | 0.5 | 0.9 |
| PP&E | 50.2 K | 3.56 K | 5.7 K | 7.36 K | 9.68 K |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 87.2 K | 6.72 K | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 19.9 | 14.9 | 18.2 | 0.5 | 0.9 |
| LIABILITIES | |||||
| Accounts Payable | 1.4 | 0.1 | 0.1 | 0.3 | 0.2 |
| Short Term Debt | 0 | 0 | 50 K | 4.1 | 4.1 |
| Other Current Liabilities | 2.3 | 1.1 | 9.1 K | 0.9 | 0.2 |
| Total Current Liabilities | 3.7 | 1.3 | 0.2 | 5.3 | 4.6 |
| Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0.5 | 0 | 0 | 0 |
| Total Liabilities | 3.7 | 1.7 | 0.2 | 5.3 | 4.6 |
| EQUITY | |||||
| Common Stock | 2 K | 1.4 K | 1.32 K | 338 | 338 |
| Retained Earnings | (53.4) | (38.0) | (29.8) | (5.4) | (4.2) |
| Other Accumulative Comprehensive Income/Loss | 0.1 | 87 K | 0.1 | 0.1 | 68.2 K |
| Total Equity | 16.2 | 13.2 | 18.0 | (4.7) | (3.6) |
| Total Liabilities and Equity | 19.9 | 14.9 | 18.2 | 0.5 | 0.9 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 17.3 | 13.2 | 13.2 | 7.8 | 7.8 |